TY - JOUR
T1 - Screening for latent tuberculosis infection in adults
T2 - US preventive services task force recommendation statement
AU - US Preventive Services Task Force
AU - Bibbins-Domingo, Kirsten
AU - Grossman, David C.
AU - Curry, Susan J.
AU - Bauman, Linda
AU - Davidson, Karina W.
AU - Epling, John W.
AU - García, Francisco A.R.
AU - Herzstein, Jessica
AU - Kemper, Alex R.
AU - Krist, Alex H.
AU - Kurth, Ann E.
AU - Landefeld, C. Seth
AU - Mangione, Carol M.
AU - Phillips, William R.
AU - Phipps, Maureen G.
AU - Pignone, Michael P.
N1 - Funding Information:
The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.
Publisher Copyright:
Copyright © 2016 American Medical Association. All rights reserved.
PY - 2016/9/6
Y1 - 2016/9/6
N2 - IMPORTANCE Tuberculosis remains an important preventable disease in the United States. An effective strategy for reducing the transmission, morbidity, and mortality of active disease is the identification and treatment of latent tuberculosis infection (LTBI) to prevent progression to active disease. OBJECTIVE To issue a current US Preventive Services Task Force (USPSTF) recommendation on screening for LTBI. EVIDENCE REVIEW The USPSTF reviewed the evidence on screening for LTBI in asymptomatic adults seen in primary care, including evidence dating from the inception of searched databases. FINDINGS TheUSPSTFfoundadequateevidencethataccuratescreeningtestsforLTBIareavailable, treatment of LTBI provides a moderate health benefit in preventing progression to active disease, and the harms of screening and treatment are small. The USPSTF has moderate certainty that screening for LTBI in persons at increased risk for infection provides a moderate net benefit. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends screening for LTBI in populations at increased risk. (B recommendation).
AB - IMPORTANCE Tuberculosis remains an important preventable disease in the United States. An effective strategy for reducing the transmission, morbidity, and mortality of active disease is the identification and treatment of latent tuberculosis infection (LTBI) to prevent progression to active disease. OBJECTIVE To issue a current US Preventive Services Task Force (USPSTF) recommendation on screening for LTBI. EVIDENCE REVIEW The USPSTF reviewed the evidence on screening for LTBI in asymptomatic adults seen in primary care, including evidence dating from the inception of searched databases. FINDINGS TheUSPSTFfoundadequateevidencethataccuratescreeningtestsforLTBIareavailable, treatment of LTBI provides a moderate health benefit in preventing progression to active disease, and the harms of screening and treatment are small. The USPSTF has moderate certainty that screening for LTBI in persons at increased risk for infection provides a moderate net benefit. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends screening for LTBI in populations at increased risk. (B recommendation).
UR - http://www.scopus.com/inward/record.url?scp=84986910149&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84986910149&partnerID=8YFLogxK
U2 - 10.1001/jama.2016.11046
DO - 10.1001/jama.2016.11046
M3 - Review article
C2 - 27599331
AN - SCOPUS:84986910149
SN - 0098-7484
VL - 316
SP - 962
EP - 969
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
IS - 9
ER -